Functional mannose-binding lectin levels in patients with end-stage renal disease on maintenance hemodialysis

Journal of Innate Immunity

Volumn 4, Issue 3, 2012, Pages 293-300

  Satomura, Atsushi ^a   Fujita, Takayuki ^a   Yanai, Mitsuru ^a   Kumasaka, Kazunari ^a   Uehara, Yuki ^a,b   Okada, Kazuyoshi ^a   Fuke, Yoshinobu ^a   Nakayama, Tomohiro ^a  

^a NIHON UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Chronic renal failure; Diabetes; ELISA; End stage renal disease; Hemodialysis; Infection; Innate immunity; Mannose binding lectin

Indexed keywords

MANNOSE BINDING LECTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, INNATE; INDIVIDUALIZED MEDICINE; KIDNEY FAILURE, CHRONIC; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; RENAL DIALYSIS;

EID: 84859922840     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000334601     Document Type: Article

References (36)

1. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B: Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008; 3: 1526-1533.
2. Girndt M, Sester M, Sester U, Kaul H, Kohler H: Molecular aspects of T-and B-cell function in uremia. Kidney Int Suppl 2001; 78:S206-S211. (Pubitemid 32144099)
3. Iida T, Umezawa K, Tanaka K, Koga Y, Nakazawa H, Satoh T: Polymorphonuclear cells in chronic hemodialysis patients have intact phagocytotic and impaired bactericidal activities. Nephron 1997; 75: 41-47. (Pubitemid 27052936)
4. Vanholder R, Ringoir S: Polymorphonuclear cell function and infection in dialysis. Kidney Int Suppl 1992; 38:S91-S95.
5. Gerez L, Madar L, Shkolnik T, Kristal B, Arad G, Reshef A, Steinberger A, Ketzinel M, Sayar D, Shasha S, et al: Regulation of interleukin-2 and interferon-gamma gene expression in renal failure. Kidney Int 1991; 40: 266-272.
6. Goldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 1980; 93: 597-613. (Pubitemid 10015190)
7. Sarnak MJ, Jaber BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000; 58: 1758-1764.
8. Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, Kimata N, Shigematsu T, Shinoda T, Syouji T, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Marubayashi S, Morita O, Yamagata K, Wakai K, Watanabe Y, Iseki K, Tsubakihara Y: Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial 2010; 14: 505-540.
9. Ando M, Shibuya A, Tsuchiya K, Akiba T, Nitta K: Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients. Kidney Int 2006; 70: 358-362. (Pubitemid 44086586)
10. Lim WH, Kireta S, Leedham E, Russ GR, Coates PT: Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients. Kidney Int 2007; 72: 1138-1148. (Pubitemid 47609031)
11. Kawasaki N, Kawasaki T, Yamashina I: Isolation and characterization of a mannan-binding protein from human serum. J Biochem 1983; 94: 937-947. (Pubitemid 13009876)
12. Wild J, Robinson D, Winchester B: Isolation of mannose-binding proteins from human and rat liver. Biochem J 1983; 210: 167-174. (Pubitemid 13141433)
13. Summerfield JA, Taylor ME: Mannose-binding proteins in human serum: Identification of mannose-specific immunoglobulins and a calcium-dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochim Biophys Acta 1986; 883: 197-206. (Pubitemid 16027981)
14. Matsushita M: The lectin pathway of the complement system. Microbiol Immunol 1996; 40: 887-893. (Pubitemid 27014313)
15. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW: Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000; 68: 688-693. (Pubitemid 30056524)
16. Ezekowitz RA, Day LE, Herman GA: A human mannose-binding protein is an acutephase reactant that shares sequence homology with other vertebrate lectins. J Exp Med 1988; 167: 1034-1046.
17. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC: The concentration of the Ctype lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992; 90: 31-35.
18. Satomura A, Fujita T, Fuke Y, Yanai M, Kumasaka K, Takayama E, Hamada H, Maruyama T, Nakayama T: Relationship between oligomer and functional serum mannose-binding lectin in chronic renal failure. Eur J Clin Invest 2010; 40: 865-873.
19. Roos A, Rastaldi MP, Calvaresi N, Oortwijn BD, Schlagwein N, van Gijlswijk-Janssen DJ, Stahl GL, Matsushita M, Fujita T, van Kooten C, Daha MR: Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol 2006; 17: 1724-1734. (Pubitemid 43794676)
20. Xing GQ, Chen M, Liu G, Zheng X, E J, Zhao MH: Differential deposition of C4d and MBL in glomeruli of patients with ANCAnegative pauci-immune crescentic glomerulonephritis. J Clin Immunol 2010; 30: 144-156.
21. Ibernon M, Moreso F, Moreno JM, Bestard O, Cruzado JM, Grinyo JM, Ricart W, Fernandez-Real JM, Seron D: Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation. Transplantation 2009; 88: 272-278.
22. Simera I, Moher D, Hoey J, Schulz KF, Altman DG: A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010; 40: 35-53.
23. Masuda M, Komiyama Y, Murakami T, Murata K: Decrease of polymorphonuclear leukocyte membrane fluidity in uremic patients on hemodialysis. Nephron 1990; 54: 36-41. (Pubitemid 19284261)
24. Vanholder R, De Smet R, Jacobs V, Van Landschoot N, Waterloos MA, Vogeleere P, Ringoir S: Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. Nephrol Dial Transplant 1994; 9: 1271-1278. (Pubitemid 24283653)
25. Jorstad S, Viken KE: Inhibitory effects of plasma from uraemic patients on human mononuclear phagocytes cultured in vitro. Acta Pathol Microbiol Scand C 1977; 85: 169-177. (Pubitemid 8127855)
26. Jorstad S, Kvernes S: Uraemic toxins of high molecular weight inhibiting human mononuclear phagocytes cultured in vitro. Acta Pathol Microbiol Scand C 1978; 86C:221-226. (Pubitemid 9043746)
27. Porter CJ, Burden RP, Morgan AG, Daniels I, Fletcher J: Impaired polymorphonuclear neutrophil function in end-stage renal failure and its correction by continuous ambulatory peritoneal dialysis. Nephron 1995; 71: 133-137.
28. Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, Turner MW: Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995; 345: 886-889.
29. Manuel O, Pascual M, Trendelenburg M, Meylan PR: Association between mannosebinding lectin deficiency and cytomegalovirus infection after kidney transplantation. Transplantation 2007; 83: 359-362.
30. Berger SP, Roos A, Mallat MJ, Schaapherder AF, Doxiadis II, van Kooten C, Dekker FW, Daha MR, de Fijter JW: Low pretransplantation mannose-binding lectin levels predict superior patient and graft survival after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol 2007; 18: 2416-2422. (Pubitemid 47203858)
31. Satomura A, Endo M, Ohi H, Sudo S, Ohsawa I, Fujita T, Matsushita M: Significant elevations in serum mannose-binding lectin levels in patients with chronic renal failure. Nephron 2002; 92: 702-704.
32. Terai I, Kobayashi K, Fujita T, Hagiwara K: Human serum mannose binding protein (MBP): Development of an enzyme-linked immunosorbent assay (ELISA) and determination of levels in serum from 1085 normal Japanese and in some body fluids. Biochem Med Metab Biol 1993; 50: 111-119. (Pubitemid 23228531)
33. Satomura A, Fujita T, Matsumoto K: Mannose-binding lectin level and polymorphism in patients on long-term peritoneal dialysis -level of serum mannose binding lectin with end-stage renal disease. Nephrol Dial Transplant 2006; 21: 1729-1730, author reply 1730-1731. (Pubitemid 44063144)
34. Satomura A, Endo M, Fujita T, Ohi H, Ohsawa I, Fuke Y, Matsumoto K, Sudo S, Matsushita M: Serum mannose-binding lectin levels in maintenance hemodialysis patients: Impact on all-cause mortality. Nephron Clin Pract 2006; 102:c93-c99. (Pubitemid 43289523)
35. Akbari R, Mireskandari M, Alizadeh-Navaei R, Ghods A: Measurement of serum levels of mannose-binding lectin in hemodialysis patients: A comparison with healthy individuals. Iran J Kidney Dis 2011; 5: 255-259.
36. Tsutsumi A, Sasaki K, Wakamiya N, Ichikawa K, Atsumi T, Ohtani K, Suzuki Y, Koike T, Sumida T: Mannose-binding lectin gene: Polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjögren's syndrome. Genes Immun 2001; 2: 99-104. (Pubitemid 33674235)